v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Revenue:        
Collaboration Revenue $ 0 $ 0 $ 16,000,000 $ 0
Grant Revenue 20,000 0 20,000 0
Total Revenue 20,000 0 16,020,000 0
Operating Expenses:        
General and Administrative 1,537,973 1,097,294 2,834,414 2,366,752
Research and Development 906,680 1,392,099 2,400,339 1,830,382
Change in Fair Value of Contingent Consideration 120,234 143,619 108,040 352,545
Total Operating Expenses 2,564,887 2,633,012 5,342,793 4,549,679
Operating Income (Loss) (2,544,887) (2,633,012) 10,677,207 (4,549,679)
Other Income, Net:        
Interest Income, Net 342,102 45,087 565,149 78,552
Other Income, Net (18,861) (25,888) (10,795) (11,222)
Total Other Income, Net 323,241 19,199 554,354 67,330
Net Income (Loss) $ (2,221,646) $ (2,613,813) $ 11,231,561 $ (4,482,349)
Net Income (Loss) per Common Share - Basic (in usd per share) $ (0.53) $ (7.15) $ 3.19 $ (15.63)
Weighted Average Shares Outstanding - Basic (in shares) 4,170,627 365,530 3,526,211 286,729
Net Income (Loss) per Common Share - Diluted (in usd per share) $ (0.53) $ (7.15) $ 2.79 $ (15.63)
Weighted Average Shares Outstanding - Diluted (in shares) 4,170,627 365,530 4,031,174 286,729
Other Comprehensive Income (Loss):        
Net Income (Loss) $ (2,221,646) $ (2,613,813) $ 11,231,561 $ (4,482,349)
Unrealized Loss on Marketable Securities (2,828) 0 (2,828) 0
Foreign Currency Translation Adjustments 21,467 (10,449) (60,106) (43,120)
Comprehensive Income (Loss) $ (2,203,007) $ (2,624,262) $ 11,168,627 $ (4,525,469)

Source